Journal of the National Comprehensive Cancer Network : JNCCN · 2021
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021.
СтатьяКлинические рекомендацииНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Swetter Susan M, Thompson John A, Albertini Mark R, Barker Christopher A, Baumgartner Joel, Boland Genevieve, Chmielowski Bartosz, DiMaio Dominick, Durham Alison, Fields Ryan C, Fleming Martin D, Galan Anjela, Gastman Brian, Grossmann Kenneth, Guild Samantha, Holder Ashley, Johnson Douglas, Joseph Richard W, Karakousis Giorgos, Kendra Kari, Lange Julie R, Lanning Ryan, Margolin Kim, Olszanski Anthony J, Ott Patrick A, Ross Merrick I, Salama April K, Sharma Rohit, Skitzki Joseph, Sosman Jeffrey, Wuthrick Evan, McMillian Nicole R, Engh Anita M
Аннотация
Over the past few years, the NCCN Guidelines for Melanoma: Cutaneous have been expanded to include pathways for treatment of microscopic satellitosis (added in v2.2020), and the following Principles sections: Molecular Testing (added in v2.2019), Systemic Therapy Considerations (added in v2.2020), and Brain Metastases Management (added in v3.2020). The v1.2021 update included additional modifications of these sections and notable revisions to Principles of: Pathology, Surgical Margins for Wide Excision of Primary Melanoma, Sentinel Lymph Node Biopsy, Completion/Therapeutic Lymph Node Dissection, and Radiation Therapy. These NCCN Guidelines Insights discuss the important changes to pathology and surgery recommendations, as well as additions to systemic therapy options for patients with advanced disease.